Changes in the diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM): a comparison of tests ordered and test Intervals in 2020 Q4 and 2023 Q4

Back

ESC Professional Premium Access

Changes in the diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM): a comparison of tests ordered and test Intervals in 2020 Q4 and 2023 Q4

Session: The different faces of cardiac amyloidosis

Topic: Infiltrative Myocardial Disease

Speaker: Mr P. Collins (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Peter Collins

Ipsos, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

9 more presentations in this session

Sustained paradoxical vasodilation and blood pressure lowering in response to sympathetic stimulation as markers of disease severity and poor survival in primary AL amyloidosis.

Speaker: Doctor K. Stamatelopoulos (Athens, GR)

Frailty and associated outcomes in patients with transthyretin cardiac amyloidosis

Speaker: Doctor C. Fumagalli (Florence, IT)

Cardiac transthyretin amyloidosis in patients with conduction system disease

Speaker: Doctor J. Pudich (Ostrava, CZ)

ATTR cardiac amyloidosis after lumbar spinal stenosis- a prospective cohort study

Speaker: Doctor P. Eldhagen (Stockholm, SE)

Clinical and laboratorial profile of patients with ATTR cardiomyopathy: comparison between wild type and p.Val142Ile forms in the Brazilian population

Speaker: Associate Professor M. Simoes (Ribeirao Preto, BR)

Access the full session

The different faces of cardiac amyloidosis

Speakers: Mr P. Collins, Doctor K. Stamatelopoulos, Doctor C. Fumagalli, Doctor J. Pudich, Doctor P. Eldhagen...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources